Fig. 5
From: Chiral pyrimidinyl-piperazine carboxamide derivatives as potent yeast α-glucosidase inhibitors
(A) RMSDs of the backbone and ligand (Lig fit Protein), (B) number of contacts, and (C) number of hydrogen bonds of 21b and 21c in complex with α-glucosidase obtained from 500-ns MD simulation.
